ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #811Top JournalHybrid

British Journal of Cancer

Acronym:bjcancer
•
Abbreviation (ISO):BR. J. CANCER
•
Identifier (ISSN):0007-0920(Print)/1532-1827(Online)
•
Publisher:Springer Nature
Clarivate IF (2026)
7.8↑ +1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for British Journal of Cancer

WoS Q1
369125.9220185.4220195.7920207.6420219.0720228.820236.420246.820257.82026
Annual Impact Factor Metric
Current (2026):7.8
Scopus SJR & RankScopus Q1
2.803
#811

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
290

290 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate1.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
376articles/year
57.64% Gold OA•84.5% Original Research

Aims & Scope

The British Journal of Cancer is one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer research. It also publishes high-quality reviews and thought-provoking comment on all aspects of cancer prevention,diagnosis and treatment.

Topics Covered (Recognized by AI)
Medicine99%Biology94.4%Genetics89.3%Internal medicine87.6%Cancer62.6%Pathology62.3%Chemistry60.8%Biochemistry54.7%Surgery36.3%Cancer research35.5%Oncology32%Immunology31.9%Gene27%Endocrinology21.5%Physics20.9%Mathematics20.7%Organic chemistry20.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank48/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank45/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF7.8
Articles / Year312
Total Citations161
2025
IF6.8
Articles / Year374
Total Citations1,659
2024
IF6.4
Articles / Year387
Total Citations5,549
2023
IF8.8
Articles / Year419
Total Citations9,288
2022
IF9.075
Articles / Year447
Total Citations13,516

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #811Scopus Q1SCImago Profile
Scopus Coverage:1947-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
2.803

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
7.15

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,030 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations9,462
3-Year Documents1,281
Citable Documents1,197

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate43.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
OncologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

British Journal of Cancer (acronym: bjcancer, abbr: BR. J. CANCER, ISSN: 0007-0920) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Nature in England since 1947. The periodical holds a Journal Impact Factor (JIF) of 7.80, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.803 (Q1), an H-index of 290.

The journal enforces rigorous peer evaluation with a publication frequency of Semimonthly, an annual output of approximately 376 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,030 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Nature
Publication Language
English
Frequency
Semimonthly
Founding Year
1947
Indexing & Databases
SCIEScopusPubMed
Editorial Address
NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 2cd33c32-feb9-4d01-98a5-e730df1aaed3
Database Updated: 2026-09-28